Compare Snap On Incorporated (SNA) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Snap On Incorporated vs Tempus AI — how do they compare? Snap On Incorporated trades at $360.37 (market cap $18.56B), while Tempus AI trades at $70.93 (market cap $12.58B). The key difference: Snap On Incorporated is the larger of the two by market cap, and Snap On Incorporated pays a 2.72% dividend while Tempus AI pays none. Which is the better fit depends on your goals — on Pluang, investors hold Snap On Incorporated for 37 Days and Tempus AI for 23 Days on average.
| SNA | TEM | |
|---|---|---|
Market Cap | $18.56B | $12.58B |
Volume | 401,326 | 7,444,569 |
Sector | Industrials | Broad Market / Factor |
52-Week High | $419.31 | $99.28 |
52-Week Low | $327.33 | $41.55 |
Typical Hold Time | 37 Days | 23 Days |
Enterprise Value | $18.20B | $13.21B |
Dividend Yield | 2.72% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Snap-On Incorporated (SNA) trades at $360.37, up 0.13% on the day, with a bearish technical outlook but strong fundamentals. The stock shows robust profitability with a 19.6% net income margin and 17.58% ROE, supported by consistent earnings beats in recent quarters. Analyst consensus is bullish with a $449 price target, though technical indicators signal selling pressure near key resistance at $361.
SNA presents a compelling investment case driven by solid earnings growth and expanding margins, but faces near-term technical headwinds and valuation risks. The stock's premium P/E of 18.31 may limit upside if growth moderates, while institutional activity shows mixed positioning. Investors should weigh strong cash flow against competitive pressures in the tools sector.
Tempus AI (TEM) trades at $69.28, down 1.44% today, with a bullish technical signal despite bearish moving averages. The company shows strong revenue growth (2026: $1.4B) but remains unprofitable with negative margins. Recent FDA clearance for ECG-MR AI product and ESMO Congress presentations highlight innovation momentum. Analyst consensus is strongly bullish with 64% buy ratings and $72.60 price target.
TEM offers growth potential in AI-driven healthcare diagnostics but carries significant execution risk due to persistent losses. The stock's high P/S ratio (8.61) reflects growth expectations, yet negative ROE (-67.44%) and insider selling warrant caution. Upside depends on profitability improvements and commercial adoption of new AI products.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Snap On Incorporated
Snap-on Incorporated is a leading global innovator, manufacturer, and marketer of tools, equipment, diagnostics, repair information, and systems solutions for professional users. Its products are widely used in vehicle service and repair, as well as in other demanding industrial environments. The company is best known for its premium tool brand, often sold through a network of franchised mobile stores, and is a primary supplier to technicians in the transportation industry.
Read more on SNA →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
